MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fossom, L. H.
Right arrow Articles by Tank, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fossom, L. H.
Right arrow Articles by Tank, A. W.

Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid

LH Fossom, CR Sterling and AW Tank

Department of Pharmacology, University of Rochester Medical Center, New York 14642.

Tyrosine hydroxylase mRNA is induced in rat pheochromocytoma PC18 cells by cAMP analogs and glucocorticoids. Previous studies have shown that these increases in tyrosine hydroxylase mRNA are due at least in part to stimulation of the tyrosine hydroxylase gene. However, the involvement of post-transcriptional mechanisms in the regulation of tyrosine hydroxylase mRNA by these inducing agents has not been investigated. In the present study, using nuclear run-on assays we show that the relative transcription rate of the tyrosine hydroxylase gene is stimulated 2-5-fold within 20 min after treatment of PC18 cells with cAMP analogs or dexamethasone and that the rate of transcription remains elevated 2-3-fold for at least 24 hr in the continual presence of these inducing agents. Pulse-labeling experiments using 4- thiouridine indicate that the rate of synthesis of tyrosine hydroxylase mRNA is increased approximately 3-fold or 10-fold after treatment with either a cyclic AMP analog or dexamethasone, respectively. These increases in rates of synthesis agree well with the fold increases in tyrosine hydroxylase mRNA levels after treatment with these inducers. Treatment of the cells with cycloheximide lowers the basal relative transcription rate of the tyrosine hydroxylase gene 2-3-fold; however, the relative transcription rate of the tyrosine hydroxylase gene is still elevated in cells treated with either dexamethasone or cAMP analogs in the presence of cycloheximide, compared with the transcription rate of the gene in cells treated with cycloheximide alone. These results indicate that protein synthesis is not required for the short term regulation of the gene by these inducing agents. The apparent t1/2 for tyrosine hydroxylase mRNA has been estimated by two different procedures, approach to steady state kinetics and pulse-chase analysis. Both procedures yield an estimated apparent t1/2 of approximately 6-9 hr for tyrosine hydroxylase mRNA under basal culture conditions. Dexamethasone does not substantially alter this apparent t1/2 value; however, cAMP appears to lower this apparent t1/2 value transiently. Our results suggest that cAMP and glucocorticoid regulate tyrosine hydroxylase mRNA levels primarily by stimulating the transcription rate of the tyrosine hydroxylase gene; however, cAMP may also regulate the stability of the mRNA for a short period of time, such that it is induced more rapidly in the cells.

Volume 42, Issue 5, pp. 898-908, 11/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Cavadas, D. Cefai, J. Rosmaninho-Salgado, M. A. Vieira-Coelho, E. Moura, N. Busso, T. Pedrazzini, D. Grand, S. Rotman, B. Waeber, et al.
Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion
PNAS, July 5, 2006; 103(27): 10497 - 10502.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. McArthur, Z.-L. Siddique, H. C. Christian, G. Capone, E. Theogaraj, C. D. John, S. F. Smith, J. F. Morris, J. C. Buckingham, and G. E. Gillies
Perinatal Glucocorticoid Treatment Disrupts the Hypothalamo-Lactotroph Axis in Adult Female, But Not Male, Rats
Endocrinology, April 1, 2006; 147(4): 1904 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Sun, X. Chen, L. Xu, C. Sterling, and A. W. Tank
Chronic Nicotine Treatment Leads to Induction of Tyrosine Hydroxylase in Locus Ceruleus Neurons: The Role of Transcriptional Activation
Mol. Pharmacol., October 1, 2004; 66(4): 1011 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, G. Eisenhofer, S. L. Mehlinger, A. Carlson, R. Wesley, M. F. Keil, G. P. Chrousos, M. I. New, and D. P. Merke
Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3031 - 3037.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al.
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Bornstein, H. Tian, A. Haidan, A. Bottner, N. Hiroi, G. Eisenhofer, S. M. McCann, G. P. Chrousos, and S. Roffler-Tarlov
Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo
PNAS, December 19, 2000; 97(26): 14742 - 14747.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. B. Nankova, M. Rivkin, M. Kelz, E. J. Nestler, and E. L. Sabban
Fos-Related Antigen 2: Potential Mediator of the Transcriptional Activation in Rat Adrenal Medulla Evoked by Repeated Immobilization Stress
J. Neurosci., August 1, 2000; 20(15): 5647 - 5653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-S. Won, J.-K. Lee, D.-K. Song, S.-O. Huh, J.-S. Jung, Y.-H. Kim, M.-R. Choi, and H.-W. Suh
Cycloheximide Increases Proenkephalin and Tyrosine Hydroxylase Gene Expression in Rat Adrenal Medulla
Mol. Pharmacol., June 1, 2000; 57(6): 1173 - 1181.
[Abstract] [Full Text]


Home page
FASEB J.Home page
S. R. BORNSTEIN, T. TAJIMA, G. EISENHOFER, A. HAIDAN, and G. AGUILERA
Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice
FASEB J, July 1, 1999; 13(10): 1185 - 1194.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
C. A. Teitsma, I. Anglade, C. Lethimonier, G. Le Dréan, D. Saligaut, B. Ducouret, and O. Kah
Glucocorticoid Receptor Immunoreactivity in Neurons and Pituitary Cells Implicated in Reproductive Functions in Rainbow Trout: A Double Immunohistochemical Study
Biol Reprod, March 1, 1999; 60(3): 642 - 650.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. R. Paulding and M. F. Czyzyk-Krzeska
Regulation of Tyrosine Hydroxylase mRNA Stability by Protein-binding, Pyrimidine-rich Sequence in the 3'-Untranslated Region
J. Biol. Chem., January 22, 1999; 274(4): 2532 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tillmann-Bogush, J. H. Heaton, and T. D. Gelehrter
Cyclic Nucleotide Regulation of PAI-1 mRNA Stability. IDENTIFICATION OF CYTOSOLIC PROTEINS THAT INTERACT WITH AN A-RICH SEQUENCE
J. Biol. Chem., January 8, 1999; 274(2): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Wang, G. Nickenig, and T. J. Murphy
The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents
Mol. Pharmacol., November 1, 1997; 52(5): 781 - 787.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. J. Swanson, E. Zellmer, and E. J. Lewis
The Homeodomain Protein Arix Interacts Synergistically with Cyclic AMP to Regulate Expression of Neurotransmitter Biosynthetic Genes
J. Biol. Chem., October 24, 1997; 272(43): 27382 - 27392.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Maurer and S. Wray
Neuronal Dopamine Subpopulations Maintained in Hypothalamic Slice Explant Cultures Exhibit Distinct Tyrosine Hydroxylase mRNA Turnover Rates
J. Neurosci., June 15, 1997; 17(12): 4552 - 4561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Nagamoto-Combs, K. M. Piech, J. A. Best, B. Sun, and A. W. Tank
Tyrosine Hydroxylase Gene Promoter Activity Is Regulated by Both Cyclic AMP-responsive Element and AP1 Sites following Calcium Influx. EVIDENCE FOR CYCLIC AMP-RESPONSIVE ELEMENT BINDING PROTEIN-INDEPENDENT REGULATION
J. Biol. Chem., February 28, 1997; 272(9): 6051 - 6058.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Norris and D. E. Millhorn
Hypoxia-induced Protein Binding to O(2)-responsive Sequences on the Tyrosine Hydroxylase Gene
J. Biol. Chem., October 6, 1995; 270(40): 23774 - 23779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lazaroff, S. Patankar, S. O. Yoon, and D. M. Chikaraishi
The Cyclic AMP Response Element Directs Tyrosine Hydroxylase Expression in Catecholaminergic Central and Peripheral Nervous System Cell Lines from Transgenic Mice
J. Biol. Chem., September 15, 1995; 270(37): 21579 - 21589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Papanikolaou and E. L. Sabban
Ability of Egr1 to Activate Tyrosine Hydroxylase Transcription in PC12 Cells. CROSS-TALK WITH AP-1 FACTORS
J. Biol. Chem., August 25, 2000; 275(35): 26683 - 26689.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics